The Company is scheduled to present at 9:20am Eastern Time the same day via webcast. A live webcast of the event can be ...

For the three months ended September 30, 2025, Syndax reported a net loss attributable to common stockholders of $60.7 million, or $0.70 per share, compared to a net loss attributable to common ...

AAM, the Biosimilars Council and NACDS commended the FDA for its announcement to make it faster and less costly to develop biosimilar medicines.

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced ...

Even though Kenvue's stock was already in a tailspin before the FDA warned pregnant woman that Tylenol posed a health risk, there are still some lingering impacts to consider.

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

Thailand’s FDA has recalled the popular 'Hong Thai' herbal inhaler, one of the most loved products by almost every traveller who has been to the country ...

Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company"), a leader in the development of differentiated targeted radiotherapies, announced today that Sandesh Seth, Chairman and CEO will be ...

A judge next month will hear arguments on Kilmar Abrego Garcia’s motion to dismiss charges of human smuggling against him on the grounds of “vindictive prosecution.” ...